8-溴-6-甲基喹啉 | 84839-95-2

• 物质功能分类: 医药中间体 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 8-溴-6-甲基喹啉
• 中文别名: 6-甲基-8-溴喹啉
• 英文名称: 8-bromo-6-methylquinoline
• 英文别名: 6-methyl-8-bromoquinoline
• CAS: 84839-95-2
• 化学式: C₁₀H₈BrN
• 分子量: 222.084
• InChiKey: ONJNEQXRWAWITH-UHFFFAOYSA-N

物化性质

• 熔点：
  51 °C
• 沸点：
  125 °C(Press: 0.2 Torr)
• 密度：
  1.488±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933499090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存放条件：室温、密封且干燥环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 8-Bromo-6-methylquinoline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 8-Bromo-6-methylquinoline
CAS number: 84839-95-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8BrN
Molecular weight: 222.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  8-溴-6-甲基喹啉 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异庚腈 作用下， 以 氯苯 为溶剂， 反应 19.0h， 以79%的产率得到8-溴-6-(溴甲基)喹啉
  参考文献：
  名称：

  PDE4抑制剂的工艺开发和大规模合成

  摘要：

  PDE4抑制剂6- [1-甲基-1-（甲基磺酰基）乙基] -8-（3-{（E）-2-（3-甲基-1,2,4-恶二唑-描述了5-基）-2- [4-（甲基磺酰基）苯基]乙烯基}苯基）喹啉苯磺酸盐（10）。合成高度收敛，通过在Knoevenagel反应中偶联醛7和恶二唑8生成倒数第二个9。该过程共包括9个化学步骤，其中5个步骤包括通过Skraup反应，溴化，砜形成，甲基化和Suzuki-Miyaura交叉偶联制备醛7的顺序，以及两步合成恶二唑的顺序8其中包括甲基ami肟和恶二唑步骤。最后两个步骤是Knoevenagel偶联和成盐。该方法以多千克规模从2-溴-4-甲基苯胺（1）以46％的总产率产生了候选药物10。

  DOI：

  10.1021/op050116l
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氯仿 、 溴 作用下， 生成 8-溴-6-甲基喹啉
  参考文献：
  名称：

  Ukai, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1931, vol. 51, p. 542,571; dtsch. Ref. S. 73, 76

  摘要：

  DOI：

文献信息

• Ligand-Free, Quinoline N-Assisted Copper-Catalyzed Nitrene Transfer Reaction To Synthesize 8-Quinolylsulfimides
  作者：Xinsheng Xiao、Sanping Huang、Shanshan Tang、Guokai Jia、Guangchuan Ou、Yangyan Li

  DOI：10.1021/acs.joc.9b00281

  日期：2019.6.21

  An efficient copper-catalyzed, quinolyl N-directed nitrene transfer reaction to 8-quinolylsulfides was described. A variety of 8-quinolylsulfimides with different functional groups were synthesized in moderate to high yields. The obtained 8-quinolylsulfimides were proved to be promising novel type of bidentate ligands in Pd(II)-catalyzed allylic alkylation.

  描述了一种有效的铜催化的，喹啉基N定向的腈转移反应生成8-喹啉基硫化物的方法。以中等至高收率合成了具有不同官能团的多种8-喹啉基亚磺酰亚胺。事实证明，在Pd（II）催化的烯丙基烷基化反应中，所获得的8-喹啉硫磺酰亚胺是有前途的新型二齿配体。
• Development and Mechanistic Study of Quinoline-Directed Acyl C–O Bond Activation and Alkene Oxyacylation Reactions
  作者：Giang T. Hoang、Dylan J. Walsh、Kathryn A. McGarry、Constance B. Anderson、Christopher J. Douglas

  DOI：10.1021/acs.joc.6b03011

  日期：2017.3.17

  acyl substituent across an alkene, oxyacylation of alkenes, using rhodium catalyzed C–O bond activation of an 8-quinolinyl ester is described. Our unsuccessful attempts at intramolecular carboacylation of ketones via C–C bond activation ultimately informed our choice to pursue and develop the intramolecular oxyacylation of alkenes via quinoline-directed C–O bond activation. We provide a full account

  描述了使用铑催化的8-喹啉基酯的羰基化作用，在烯烃上进行烷氧基和酰基取代基的分子内加成，烯烃的氧酰化。我们通过C-C键活化进行酮类分子内碳酰化的失败尝试最终使我们选择了通过喹啉定向的C-O键活化来追求和发展烯烃的分子内氧酰化。我们全面介绍了我们的催化剂发现，底物范围以及喹啉导向的烯烃氧酰化反应的机理实验。
• Ruthenium-catalyzed remote C5-sulfonation of <i>N</i>-alkyl-8-aminoquinolines
  作者：Xuri Liu、Han Zhang、Fanzhi Yang、Bo Wang

  DOI：10.1039/c9ob01357a

  日期：——

  demand for the methodologies of positionally selective remote C-H functionalizations. We herein report the ruthenium-catalyzed remote C5-selective sulfonation of 8-aminoquinoline derivatives. Moderate to high yields were obtained with different substituted substrates. The catalytic system exhibited a high regio-selectivity, as well as good functional group tolerance. Mechanistic study supported a radical

  对位置选择性远程CH功能化的方法学的需求不断增长。我们在此报告了8-氨基喹啉衍生物的钌催化的远程C5-选择性磺化。使用不同的取代底物可获得中等至高收率。该催化体系表现出高的区域选择性以及良好的官能团耐受性。机理研究支持一个根本途径。提出了双功能钌催化循环。
• From Anilines to Quinolines: Iodide- and Silver-Mediated Aerobic Double C−H Oxidative Annulation-Aromatization
  作者：Jiwei Wu、Zhixiong Liao、Dong Liu、Chien-Wei Chiang、Zheng Li、Zhonghao Zhou、Hong Yi、Xu Zhang、Zixin Deng、Aiwen Lei

  DOI：10.1002/chem.201703218

  日期：2017.11.13

  Quinoline synthesis from easily accessible raw materials such as anilines is a valuable and meaningful task. Herein, we communicate an iodide‐ and silver‐mediated C−H/C−H oxidative annulation–aromatization between anilines and allyl alcohols. This protocol provides a direct route to the synthesis of quinoline derivatives from inexpensive commodities. Various kinds of anilines, even heterocyclic anilines

  由苯胺等容易获得的原料合成喹啉是一项宝贵而有意义的任务。在本文中，我们传达了苯胺和烯丙醇之间碘化物和银介导的CH / CH氧化环化-芳香化反应。该协议提供了从廉价商品合成喹啉衍生物的直接途径。各种苯胺，甚至杂环苯胺，都是可行的底物，可产生高收率的相应多取代喹啉。
• Substituted Heterocyclic Ethers and Their Use in CNS Disorders
  申请人：Schmitz William D.

  公开号：US20090018163A1

  公开（公告）日：2009-01-15

  The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.

  这项发明涵盖了Formula I的化合物，包括药用盐，它们的药物组合物，以及它们在治疗中枢神经系统疾病中的用途。